For type 2 diabetes trials applying typical criteria (age 1875 years, BMI 25 kg/m 2 , HbA1c 7.010.0%, eGFR 30 mL/min/1.73m 2 ), final eligibility was uniformly low across populations: 4.1% for Non-Asian US, 1.5% for Asian US, and 2.1% for Korean adults, with the HbA1c requirement representing the primary exclusion criterion
Others may need medical nutrition therapy, obesity medicines, endoscopic options or bariatric surgery depending on their BMI, eating behaviour, diabetes status, sleep issues and long-term weight history
Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study
10.1111/dom.12540 5 ArodaV
Martof, 1956b)